An animal study, published ahead of print in the Journal of the American College of Cardiology, indicates that renal denervation delivered through high-intensity focused ultrasound (HIFU) extracorpeal renal denervation may be an alternative approach to managing resistant hypertension as it is associated with blood pressure reduction without significant morbidity or mortality.
Un estudio de Taiwán sugiere que quienes padecen hepatitis C crónica tendrían menos riesgo de desarrollar cáncer hepático si toman fármacos para reducir el colesterol. Esto no prueba que las estatinas previenen el cáncer y un científico ajeno al estudio dice que no hay motivo suficiente para recomendar el uso de esos fármacos para evitar el cáncer de hígado.
Aunque durante una histerectomía también se suelen extirpar los ovarios, un nuevo estudio sugiere que dejarlos intactos sería más beneficioso. Un equipo halló que la extirpación ovárica reducía el riesgo de cáncer de ovario, pero a la vez que potenciaba el riesgo de morir por otras causas más comunes.
The SEATTLE II study, which will investigate the safety and efficacy of ultrasound accelerated thrombolysis with the EkoSonic Endovascular System (EKOS Corporation) for the treatment of massive and submassive pulmonary embolism, has completed enrolment. SEATTLE II is a 150-patient, single-arm prospective study measuring the rapid reduction in right heart strain in a patient population with both massive and submassive pulmonary embolism.
Los procedimientos mínimamente invasivos para operar el corazón y extirpar los fibroides serían más económicos y causarían menos ausencias laborales que las cirugías convencionales.
Un nuevo estudio revela que algunos hospitales implantan filtros en los vasos sanguíneos de más de un tercio de sus pacientes que desarrollan coágulos que podrían llegar a los pulmones, pese a que aún no existen pruebas científicas de que el dispositivo salve vidas.
Vascular Solutions has announced that it has commenced sales of the PolarCath peripheral dilatation system in the United States in collaboration with NuCryo Vascular, the manufacturer of the product.
On 13 March 2013 Boston Scientific announced it is supporting several public education initiatives throughout March to highlight the prevalence and prevention of cancers of the colon and rectum as part of Colorectal Cancer Awareness Month.
Results of the ULTIMA pulmonary embolism trial comparing endovascular therapy to standard of care were presented at the American College of Cardiology meeting in San Francisco, USA, by Nils Kucher, University Hospital, Bern, Switzerland.
Merit Medical Systems announced on 7 March 2013 that it has received the CE mark to market in the European Union its line of Embosphere microspheres for embolization of the prostate gland for relief of symptoms related to benign prostatic hyperplasia.
At the ACC, 24-month data for the Symplicity renal denervation system showed that patients (number = 40) initially randomised to the intervention, compared with their baseline levels, had a sustained sustained significant drop in blood pressure (-29/-10 mmHg; p<0.01]).
Cordis announced it has completed the acquisition of Flexible Stenting Solutions, a leading developer of innovative flexible peripheral arterial, venous and biliary stents on 12 March 2013.
On 8 March 2013, Philips introduced three new imaging systems to help radiology departments increase both the number of patients and range of clinical exams they can handle. Philips is continuing the Imaging 2.0 journey to deliver greater collaboration and integration, increased patient focus and improved economic value. The imaging systems were showcased at the European Congress of Radiology (ECR) 2013 (7–11 March Vienna, Austria), all three systems combine the capabilities for high patient throughput with the functionality and advanced clinical imaging applications.
Luminos Fusion, according to the company is has two-in-one functionality, with flat panel detector technology allows more effective use of fluoroscopy equipment in routine medical care. The flat panel detector enables faster examinations and patient throughput compared to the mid-range image intensifiers that have been available up to now.
Toshiba announced on 8 March 2013 a scientific co-operation with VU medisch centrum (VUmc) for research into dementia and neuro-degenerative conditions.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos